loading page

A case of BNT162b2 COVID-19 vaccine-associated fulminant myocarditis in a very elderly woman
  • +4
  • Kaishi Otsuka,
  • Takashi Matsuo,
  • Takashi Ishimatsu,
  • Atsuki Fukae,
  • Takuro Hamamoto,
  • Koji Oku,
  • Masahiro Ito
Kaishi Otsuka
National Hospital Organisation Nagasaki Medical Center

Corresponding Author:[email protected]

Author Profile
Takashi Matsuo
National Hospital Organisation Nagasaki Medical Center
Author Profile
Takashi Ishimatsu
National Hospital Organisation Nagasaki Medical Center
Author Profile
Atsuki Fukae
National Hospital Organisation Nagasaki Medical Center
Author Profile
Takuro Hamamoto
National Hospital Organisation Nagasaki Medical Center
Author Profile
Koji Oku
National Hospital Organisation Nagasaki Medical Center
Author Profile
Masahiro Ito
National Hospital Organisation Nagasaki Medical Center
Author Profile

Abstract

Coronavirus disease 2019 (COVID-19) vaccination is reportedly safe and effective. The histologic features of post-COVID-19 vaccination myocarditis are unknown. We present a 77-year-old Japanese woman who was diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after receiving the second dose of BNT162b2 COVID-19 vaccine. Methylprednisolone pulse therapy was effective.
16 Jan 2022Submitted to Clinical Case Reports
27 Jan 2022Submission Checks Completed
27 Jan 2022Assigned to Editor
29 Jan 2022Reviewer(s) Assigned
02 Mar 2022Review(s) Completed, Editorial Evaluation Pending
02 Mar 2022Editorial Decision: Revise Minor
11 Mar 20221st Revision Received
15 Mar 2022Submission Checks Completed
15 Mar 2022Assigned to Editor
15 Mar 2022Review(s) Completed, Editorial Evaluation Pending
20 Mar 2022Editorial Decision: Revise Minor
13 Apr 20222nd Revision Received
15 Apr 2022Assigned to Editor
15 Apr 2022Submission Checks Completed
15 Apr 2022Review(s) Completed, Editorial Evaluation Pending
22 Apr 2022Editorial Decision: Accept
Sep 2022Published in Clinical Case Reports volume 10 issue 9. 10.1002/ccr3.6161